DEVELOPMENT OF A FENTANYL PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL AND EVALUATION OF DRUG-DRUG INTERACTIONS WITH TRIAZOLE ANTIFUNGAL AGENTS.

被引：0
|
作者：
Carreno, F. [1 ]
Edginton, A. [2 ]
Gonzalez, D. [1 ]
机构：
[1] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[2] Univ Waterloo, Waterloo, ON, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-033
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [21] Physiologically-based model for ketoconazole disposition and prediction of its drug-drug interactions
    Fraczkiewicz, Grazyna
    Parrott, Neil
    Lukacova, Viera
    Bolger, Michael B.
    Crison, John R.
    Woltosz, Walter S.
    Lave, Thierry
    [J]. DRUG METABOLISM REVIEWS, 2009, 41 : 82 - 83
  • [22] Modeling the complexity of drug-drug interactions: A physiologically-based pharmacokinetic study of Lenvatinib with Schisantherin A/Schisandrin A
    Zheng, Aole
    Yang, Dongsheng
    Pan, Chunyang
    He, Qingfeng
    Zhu, Xiao
    Xiang, Xiaoqiang
    Ji, Peiying
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 196
  • [23] Evaluation of the drug-drug interaction potential of treosulfan using a physiologically-based pharmacokinetic modelling approach
    Schaller, Stephan
    Martins, Frederico S.
    Balazki, Pavel
    Bohm, Sonja
    Baumgart, Joachim
    Hilger, Ralf A.
    Beelen, Dietrich W.
    Hemmelmann, Claudia
    Ring, Arne
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (04) : 1722 - 1734
  • [24] Evaluation of the drug-drug interaction potential of brigatinib using a physiologically-based pharmacokinetic modeling approach
    Hanley, Michael J.
    Yeo, Karen Rowland
    Tugnait, Meera
    Iwasaki, Shinji
    Narasimhan, Narayana
    Zhang, Pingkuan
    Venkatakrishnan, Karthik
    Gupta, Neeraj
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (04): : 624 - 637
  • [25] Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug-Drug Interactions of Phenytoin
    Rodriguez-Vera, Leyanis
    Yin, Xuefen
    Almoslem, Mohammed
    Romahn, Karolin
    Cicali, Brian
    Lukacova, Viera
    Cristofoletti, Rodrigo
    Schmidt, Stephan
    [J]. PHARMACEUTICS, 2023, 15 (10)
  • [26] INVESTIGATING TRANSPORTER-MEDIATED DRUG-DRUG INTERACTIONS (DDIS) OF DASATINIB USING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL.
    Chang, M.
    Bathena, S.
    Christopher, L.
    Shen, H.
    Roy, A.
    Leil, T.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S7 - S7
  • [27] A physiologically-based pharmacokinetic (PBPK) model of hydroxychloroquine
    Collins, Keagan P.
    Jackson, Kristen M.
    Gustafson, Daniel L.
    [J]. CANCER RESEARCH, 2017, 77
  • [28] ESTABLISHING A VERSATILE ANALYSIS METHOD OF DRUG-DRUG INTERACTIONS WITH THE PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL USING THE CLUSTER NEWTON METHOD
    Toshimoto, Kota
    Yoshida, Kenta
    Yoshikado, Takashi
    Maeda, Kazuya
    Kusuhara, Hiroyuki
    Konagaya, Akihiko
    Sugiyama, Yuichi
    [J]. DRUG METABOLISM REVIEWS, 2015, 47 : 231 - 232
  • [29] ANALYSIS OF DRUG-DRUG INTERACTIONS BETWEEN CERIVASTATIN AND INTERACTING DRUGS, CYCLOSPORINE A AND GEMFIBROZIL, USING PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODEL
    Kim, Soo-Jin
    Yao, Yoshiaki
    Yoshikado, Takashi
    Toshimoto, Kota
    Sugiyama, Yuichi
    [J]. DRUG METABOLISM REVIEWS, 2015, 47 : 115 - 115
  • [30] Physiologically based pharmacokinetic modelling of oxycodone drug-drug interactions
    Rytkonen, Jaana
    Ranta, Veli-Pekka
    Kokki, Merja
    Kokki, Hannu
    Hautajarvi, Heidi
    Rinne, Valtteri
    Heikkinen, Aki T.
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 2020, 41 (1-2) : 72 - 88
12345